Radiation Therapy Side-Effects
Radiation Therapy Side-Effects arise when ionizing radiation used to treat or control cancer also impacts healthy cells, leading to symptoms such as hair loss, dermatitis, and fatigue. The specific side effects depend on the body parts treated and may vary in severity among patients.
Health Outcomes
- Absence of Treatment-Associated Bacterial Translocation
- Adverse Effects Frequency
- Adverse Events
- Altered Intestinal Mucosa Morphology
- Association with Serious Adverse Events
- Cancer-Related Supportive Effects
- Delayed Onset of Grade 2 Dermatitis
- Delayed Onset of Grade 3 Dermatitis
- Delayed Oral Mucositis Onset
- Enhanced Wound Healing
- Impaired Spermatogenesis
- Improved Cancer Treatment Tolerance
- Improved Cancer-Related Health Outcome
- Improved Cell Survival Rates
- Improved Mouth Opening Limitation
- Improved Oral Mucositis
- Improved Oral Mucositis Healing
- Improved Recovery in Immunocompromised Individuals
- Improved Safety Profile
- Improved Secondary Outcomes
- Improved Taste Function
- Improved Taste Sensation
- Improved Tissue Healing
- Improved Tolerability
- Improved Treatment Efficacy for Radiation-Induced Pulmonary Injury
- Improved Treatment Safety
- Increased Adverse Effects
- Increased Adverse Event Incidence
- Increased Adverse Events
- Increased Adverse Reactions
- Increased Cytotoxicity and Mucosal Damage Risk
- Increased Expression of Pro-apoptotic Proteins
- Increased Healing Rate
- Increased Mucosal Thickness
- Maintained Cell Viability
- No Mutagenicity
- Occurrence of Adverse Events
- Prevention of Intestinal Radiation Syndrome
- Protection Against Radiological Damage
- Reduced Acute Radiation Enteritis Severity
- Reduced Adverse Effects
- Reduced Adverse Event
- Reduced Adverse Event Frequency
- Reduced Adverse Reaction
- Reduced Antiemetic Medication Use
- Reduced Bowel Toxicity-Related Hospital Care
- Reduced Breast Fullness
- Reduced Cancer-Related Fatigue
- Reduced Chemoradiotherapy-Related Adverse Event
- Reduced Clinical Oral Dryness Score
- Reduced DNA Strand Break in Peripheral Blood Mononuclear Cell
- Reduced Debridement Time
- Reduced Dysgeusia
- Reduced Gastrointestinal Adverse Events
- Reduced Gastrointestinal Toxicity
- Reduced Immunosuppression-Related Spleen Injury
- Reduced Incidence of Oral Mucositis
- Reduced Incidence of Total Adverse Effects
- Reduced Intestinal Mucositis Severity
- Reduced Lesion Healing Time
- Reduced Mucosal Thickness
- Reduced Mucositis
- Reduced Nausea and Vomiting Score
- Reduced Nausea and Vomiting Severity
- Reduced Oral Burning
- Reduced Oral Candida Colonization
- Reduced Oral Mucositis
- Reduced Oral Mucositis Severity
- Reduced Oral Mucositis Symptoms
- Reduced Pigmentation
- Reduced Prolactin Secretion
- Reduced Radiation-Associated Diarrhea
- Reduced Radiation-Induced Dermatitis Severity
- Reduced Radiation-Induced Diarrhea Incidence
- Reduced Radiation-Induced Oral Mucositis
- Reduced Radiation-Induced Pulmonary Injury
- Reduced Radiological Damage in the Gut
- Reduced Saliva Volume
- Reduced Severe Oral Mucositis Duration
- Reduced Side Effect
- Reduced Thyroid Gland Volume
- Reduced Thyroid Volume
- Reduced Vaginal Discharge
- Reduced Vomiting
- Reduced Vomiting Duration
- Reduced Vomiting Frequency
- Reduced Vomiting Incidence
- Reduced Vomiting Symptoms
- Reduced Watering Frequency
- Reduced Xerostomia
- Regressed Esophagitis
- Safety And Tolerability
- Stable Adverse Drug Reaction Rate
- Supportive Effect in Breast Cancer Management